July 2019 - Holland & Barrett is one of the world’s leading health and wellness retailers and the largest in Europe. The major retailer has been expanding its range of CBD - an active substance found in hemp oil, extracted from the leaves and flowers of the hemp plant.
Australian listed Creso Pharma (ASX:CPH) has just secured retail distribution in both Holland & Barrett and Boots in the United Kingdom for its product cannaQIX®. Creso and its partner Pharmacare Europe are selling the product under the brand Naturopathica and product name Naturopathica CBD Lozenges and The Capital Network's Executive Director Lelde Smits travelled to London to learn how Holland & Barrett is expanding its CBD range.
Creso Pharma’s CEO and Co‐Founder Dr. Miri Halperin Wernli says: “Accelerating the commercialization of cannaQIX® through distribution to the UK’s largest retailers is an exciting milestone for Creso Pharma. Our partnership with Pharmacare Europe has proved successful and been validated by significant distribution with recognised and respected retailers Boots and Holland & Barrett. With cannaQIX® we offer consumers a safe and effective certified Food Supplement with CBD which has broad market access without the need for medical prescription."
To learn more please visit: www.cresopharma.com